The effect of the postmortem interval on the redistribution of drugs: A comparison of mortuary admission and autopsy blood specimens

Forensic Science, Medicine, and Pathology

Volumn 8, Issue 4, 2012, Pages 373-379

  Gerostamoulos, Dimitri ^a,b   Beyer, Jochen ^a,b   Staikos, Voula ^a   Tayler, Penny ^a   Woodford, Noel ^a   Drummer, Olaf H ^a,b  

^a VICTORIAN INSTITUTE OF FORENSIC MEDICINE   (Australia)

^b MONASH UNIVERSITY   (Australia)

Author keywords

Femoral blood; Forensic autopsy; Heart blood; Postmortem interval; Postmortem redistribution; Toxicology

Indexed keywords

EID: 84867635996     PISSN: 1547769X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12024-012-9341-2     Document Type: Article

References (64)

1. Drummer OH, Gerostamoulos J. Postmortem drug analysis: analytical and toxicological aspects. Ther Drug Monit. 2002; 24(2): 199-209.
2. Yarema MC, Becker CE. Key concepts in postmortem drug redistribution. Clin Toxicol (Phila). 2005; 43(4): 235-41.
3. Ferner RE. Postmortem clinical pharmacology. Br J Clin Pharmacol. 2008; 66(4): 430-43.
4. Pélissier-Alicot AL, Gaulier JM, Champsaur P, Marquet P. Mechanisms underlying postmortem redistribution of drugs: a review. J Anal Toxicol. 2003; 27(8): 533-44.
5. Skopp G. Postmortem toxicology. Forensic Sci Med Pathol. 2010; 6(4): 314-25.
6. Jones GR, Pounder DJ. Site dependence of drug concentrations in postmortem blood-a case study. J Anal Toxicol. 1987; 11(5): 186-90.
7. Prouty RW, Anderson WH. A comparison of postmortem heart blood and femoral blood ethyl alcohol concentrations. J Anal Toxicol. 1987; 11(5): 191-7.
8. Kuhlman JJ Jr, Mayes RW, Levine B, Jones R, Wagner GN, Smith ML. Chloroquine distribution in postmortem cases. J Forensic Sci. 1991; 36(5): 1572-9.
9. Hilberg T, Mørland J, Bjørneboe A. Postmortem release of amitriptyline from the lungs; a mechanism of postmortem drug redistribution. Forensic Sci Int. 1994; 64(1): 47-55.
10. McIntyre IM, King CV, Cordner SM, Drummer OH. Postmortem clomipramine: therapeutic or toxic concentrations? J Forensic Sci. 1994; 39(2): 486-93.
11. Pounder DJ, Hartley AK, Watmough PJ. Postmortem redistribution and degradation of dothiepin: human case studies and an animal model. Am J Forensic Med Pathol. 1994; 15(3): 231-5.
12. Logan BK, Smirnow D. Postmortem distribution and redistribution of morphine in man. J Forensic Sci. 1996; 41(2): 221-9.
13. Pohland RC, Bernhard NR. Postmortem serum and tissue redistribution of fluoxetine and norfluoxetine in dogs following oral administration of fluoxetine hydrochloride (Prozac®). J Forensic Sci. 1997; 42(5): 812-6.
14. Robertson MD, Drummer OH. Postmortem distribution and redistribution of nitrobenzodiazepines in man. J Forensic Sci. 1998; 43(1): 9-13.
15. Barnhart FE, Fogacci JR, Reed DW. Methamphetamine-a study of postmortem redistribution. J Anal Toxicol. 1999; 23(1): 69-70.
16. Couper FJ, Drummer OH. Postmortem stability and interpretation of β2-agonist concentrations. J Forensic Sci. 1999; 44(3): 523-6.
17. Jaffe PD, Batziris HP, van der Hoeven P, et al. A study involving venlafaxine overdoses: comparison of fatal and therapeutic concentrations in postmortem specimens. J Forensic Sci. 1999; 44(1): 193-6.
18. Kunsman GW, Rodriguez R, Rodriguez P. Fluvoxamine distribution in postmortem cases. Am J Forensic Med Pathol. 1999; 20(1): 78-83.
19. Gerostamoulos J, Drummer OH. Postmortem redistribution of morphine and its metabolites. J Forensic Sci. 2000; 45(4): 843-5.
20. Kerswill RM, Vicente MR. Clozapine and postmortem redistribution. Am J Psychiatry. 2003; 160(1): 184.
21. Rodda KE, Drummer OH. The redistribution of selected psychiatric drugs in postmortem cases. Forensic Sci Int. 2006; 164(2-3): 235-9.
22. Olson KN, Luckenbill K, Thompson J, Middleton O, Geiselhart R, Mills KM, Kloss J, Apple FS. Postmortem redistribution of fentanyl in blood. Am J Clin Pathol. 2010; 133(3): 447-53.
23. Moriya F, Hashimoto Y. Pericardial fluid as an alternative specimen to blood for postmortem toxicological analyses. Legal Med. 1999; 1(2): 86-94.
24. Moriya F, Hashimoto Y. Redistribution of basic drugs into cardiac blood from surrounding tissues during early-stages postmortem. J Forensic Sci. 1999; 44(1): 10-6.
25. Yarema MC, Becker CE. Key concepts in postmortem drug redistribution. Clin Toxicol. 2005; 43(4): 235-41.
26. Pelissier-Alicot AL, Coste N, Bartoli C, Piercecchi-Marti MD, Sanvoisin A, Gouvernet J, Leonetti G. Comparison of ethanol concentrations in right cardiac blood, left cardiac blood and peripheral blood in a series of 30 cases. Forensic Sci Int. 2006; 156(1): 35-9.
27. Pok PRP, Haddouche D, Mauras M, Kuhlmann E, Burle J, Salmon T, Berland E, Coiffait PE, Viala A. Cardiac and peripheral blood similarities in the comparison of nordiazepam and bromazepam blood concentrations. J Anal Toxicol. 2008; 32(9): 782-6.
28. Drummer OH. Forensic toxicology. EXS. 2010; 100: 579-603.
29. Prouty RW, Anderson WH. The forensic science implications of site and temporal influences on postmortem blood-drug concentrations. J Forensic Sci. 1990; 35(2): 243-70.
30. Butzbach DM. The influence of putrefaction and sample storage on postmortem toxicology results. Forensic Sci Med Pathol. 2010; 6(1): 35-45.
31. Hearn WL, Keran EE, Huang W, Hime G. Site-dependent postmortem changes in blood cocaine concentrations. J Forensic Sci. 1991; 36(3): 673-84.
32. Saar E, Gerostamoulos D, Dummer OH, et al. Identification and quantification of 30 antipsychotics in blood using LC-MS/MS. J Mass Spectrom. 2010; 45(8): 915-25.
33. Cook DS, Braithwaite RA, Hale KA. Estimating antemortem drug concentrations from postmortem blood samples: the influence of postmortem redistribution. J Clin Pathol. 2000; 53(4): 282-5.
34. Drummer O, Forrest AR, Goldberger B, Karch SB. Forensic science in the dock. BMJ. 2004; 329(7467): 636-7.
35. Karch SB. Is postmortem toxicology quackery? J Clin Forensic Med. 2003; 10(3): 197-8.
36. Flanagan RJ, Connally G, Evans JM. Analytical toxicology: guidelines for sample collection postmortem. Toxicol Rev. 2005; 24(1): 63-71.
37. Forrest AR. ACP Broadsheet no 137: April 1993. Obtaining samples at post mortem examination for toxicological and biochemical analyses. J Clin Pathol. 1993; 46(4): 292-6.
38. Kennedy MC. Postmortem drug concentrations. Intern Med J. 2010; 40(3): 183-7.
39. Dinis-Oliveira RJ, Carvalho F, Duarte JA, et al. Collection of biological samples in forensic toxicology. Toxicol Mech Methods. 2010; 20(7): 363-414.
40. Drummer OH. Postmortem toxicology of drugs of abuse. Forensic Sci Int. 2004; 142(2-3): 101-13.
41. Skopp G. Preanalytic aspects in postmortem toxicology. Forensic Sci Int. 2004; 142(2-3): 75-100.
42. Drummer OH. Postmortem toxicology. Forensic Sci Int. 2007; 165(2-3): 199-203.
43. Hepler BR, Isenschmid DS, Schmidt CJ. postmortem redistribution: practical considerations in death investigation, presented at the American Academy of Forensic Sciences: Dallas: 2004. Abstract K-14.
44. Rohrig TP, Prouty RW. Fluoxetine overdose: a case report. J Anal Toxicol. 1989; 13(5): 305-7.
45. Rohrig TP, Prouty RW. A nortriptyline death with unusually high tissue concentrations. J Anal Toxicol. 1989; 13(5): 303-4.
46. Anderson DT, Fritz KL, Muto JJ. Distribution of mirtazapine (Remeron) in thirteen postmortem cases. J Anal Toxicol. 1999; 23(6): 544-8.
47. Levine B, Jenkins AJ, Smialek JE. Distribution of sertraline in postmortem cases. J Anal Toxicol. 1994; 18(5): 272-4.
48. Tolliver SSH, Lee W, Furton KG. Evaluating the relationship between postmortem and antemortem morphine and codeine concentrations in whole blood. J Anal Toxicol. 2010; 34: 491-7.
49. Gerostamoulos J, Burke MP, Drummer OH. Involvement of codeine in drug-related deaths. Am J Forensic Med Pathol. 1996; 17(4): 327-35.
50. Sousa T, Paterson R, Moore V, Carlsson A, Abrahamsson B, Basit AW. The gastrointestinal microbiota as a site for the biotransformation of drugs. Int J Pharm. 2008; 363(1-2): 1-25.
51. Karch S. Response to postcard from Sweden. J Forensic Leg Med. 2009; 16(8): 501-2.
52. Carroll FT, Marraccini JV, Lewis S, Wright W. Morphine-3-d glucuronide stability in postmortem specimens exposed to bacterial enzymatic hydrolysis. Am J Forensic Med Pathol. 2000; 21(4): 323-9.
53. Rook EJ, Huitema ADR, van den Brink W, van Ree JM, Beijnen JH. Pharmacokinetics and pharmacokinetic variability of heroin and its metabolites: review of the literature. Curr Clin Pharmacol. 2006; 1(1): 109-18.
54. Peters FT, Schaefer S, Staack RF, et al. Screening for and validated quantification of amphetamines and of amphetamine- and piperazine-derived designer drugs in human blood plasma by gas chromatography/mass spectrometry. J Mass Spectrom. 2003; 38(6): 659-76.
55. Holmgren P, Druid H, Holmgren A, et al. Stability of drugs in stored postmortem femoral blood and vitreous humor. J Forensic Sci. 2004; 49(4): 820-5.
56. Stevens HM. The stability of some drugs and poisons in putrefying human liver tissues. J Forensic Sci Soc. 1984; 24(6): 577-89.
57. Saukko PJ, Knight B. Knight's forensic pathology. 3rd ed. London: Arnold; 2004.
58. Robertson MD, Drummer OH. Postmortem drug metabolism by bacteria. J Forensic Sci. 1995; 40(3): 382-6.
59. Giaginis C, Tsantili-Kakoulidou A, Theocharis S. Quantitative structure-activity relationship (QSAR) methodology in forensic toxicology: modeling postmortem redistribution of structurally diverse drugs using multivariate statistics. Forensic Sci Int. 2009; 190(1-3): 9-15.
60. Jones GR, Peat MA. Forensic toxicology laboratory guidelines. J Anal Toxicol. 1999; 23(7): 636.
61. Hargrove VM, McCutcheon JR. Comparison of drug concentrations taken from clamped and unclamped femoral vessels. J Anal Toxicol. 2008; 32(8): 621-5.
62. Hilberg T, Bugge A, Beylich KM, Mørland J, Bjørneboe A. Diffusion as a mechanism of postmortem drug redistribution: an experimental study in rats. Int J Legal Med. 1992; 105(2): 87-91.
63. Caplehorn JR, Drummer OH. Methadone dose and postmortem blood concentration. Drug Alcohol Rev. 2002; 21(4): 329-33.
64. Baselt RC. Disposition of toxic drugs and chemicals in man. 9th ed. Seal Beach: Biomedical Publications; 2011.